Terms: = Brain cancer AND MDM2, HDM2, 4193, ENSG00000135679, HDMX, MGC71221, hdm2, Q00987 AND Diagnosis
24 results:
1. Glioblastoma Therapy: Past, Present and Future.
Obrador E; Moreno-Murciano P; Oriol-Caballo M; López-Blanch R; Pineda B; Gutiérrez-Arroyo JL; Loras A; Gonzalez-Bonet LG; Martinez-Cadenas C; Estrela JM; Marqués-Torrejón MÁ
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473776
[TBL] [Abstract] [Full Text] [Related]
2. Genetic alterations that deregulate RB and PDGFRA signaling pathways drive tumor progression in IDH2-mutant astrocytoma.
Tateishi K; Miyake Y; Nakamura T; Iwashita H; Hayashi T; Oshima A; Honma H; Hayashi H; Sugino K; Kato M; Satomi K; Fujii S; Komori T; Yamamoto T; Cahill DP; Wakimoto H
Acta Neuropathol Commun; 2023 Nov; 11(1):186. PubMed ID: 38012788
[TBL] [Abstract] [Full Text] [Related]
3. Polymorphisms in
Morais de Castro E; Barbosa LV; Simoneti Fonseca A; Nagashima S; Busatta Vaz de Paula C; Zeni R; Panini do Carmo LA; Cavalli LR; Bleggi Torres LF; Senff Ribeiro A; de Noronha L; Machado-Souza C
ASN Neuro; 2023; 15():17590914231153481. PubMed ID: 36714975
[TBL] [Abstract] [Full Text] [Related]
4. IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutation.
Barresi V; Simbolo M; Mafficini A; Martini M; Calicchia M; Piredda ML; Ciaparrone C; Bonizzato G; Ammendola S; Caffo M; Pinna G; Sala F; Lawlor RT; Ghimenton C; Scarpa A
Acta Neuropathol Commun; 2021 Dec; 9(1):200. PubMed ID: 34952640
[TBL] [Abstract] [Full Text] [Related]
5. FMR1/circCHAF1A/miR-211-5p/HOXC8 feedback loop regulates proliferation and tumorigenesis via mdm2-dependent p53 signaling in GSCs.
Jiang Y; Wang Z; Ying C; Hu J; Zeng T; Gao L
Oncogene; 2021 Jun; 40(24):4094-4110. PubMed ID: 34017077
[TBL] [Abstract] [Full Text] [Related]
6. Cerebral pleomorphic liposarcoma: Clinicopathologic findings.
Verdugo D; Voltaggio L; Hoot A; Rodriguez FJ
Clin Neuropathol; 2019; 38(5):233-237. PubMed ID: 31347491
[TBL] [Abstract] [Full Text] [Related]
7. Research on miR-126 in glioma targeted regulation of PTEN/PI3K/Akt and mdm2-p53 pathways.
Chen SR; Cai WP; Dai XJ; Guo AS; Chen HP; Lin GS; Lin RS
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3461-3470. PubMed ID: 31081101
[TBL] [Abstract] [Full Text] [Related]
8. Clinical evaluation of a dedicated next generation sequencing panel for routine glioma diagnostics.
Synhaeve NE; van den Bent MJ; French PJ; Dinjens WNM; Atmodimedjo PN; Kros JM; Verdijk R; Dirven CMF; Dubbink HJ
Acta Neuropathol Commun; 2018 Nov; 6(1):126. PubMed ID: 30470264
[TBL] [Abstract] [Full Text] [Related]
9. [Li-Fraumeni syndrome in a patient with multiple anaplastic oligodendrogliomas of the brain (a case report and literature review)].
Potapov AA; Abdilatipov AA; Okhlopkov VA; Gavrilov AG; Zakharova NE; Goryaynov SA; Kobyakov GL; Absalyamova OV; Kravchuk AD; Kulikov AS; Shugay SV; Nikitin PV; Batalov AI; Shelygin YA; Lyubchenko LN; Aliev MD; Spallone A
Zh Vopr Neirokhir Im N N Burdenko; 2018; 82(4):87-96. PubMed ID: 30137042
[TBL] [Abstract] [Full Text] [Related]
10. CMIP Promotes Proliferation and Metastasis in Human Glioma.
Wang B; Wu ZS; Wu Q
Biomed Res Int; 2017; 2017():5340160. PubMed ID: 28744466
[TBL] [Abstract] [Full Text] [Related]
11. Metachronous cardiac and cerebral sarcomas: case report with focus on molecular findings and review of the literature.
Guerriero A; Giovenali P; La Starza R; Mecucci C; Montesi G; Pasquino S; Pierini T; Ragni T; Sidoni A
Hum Pathol; 2015 Mar; 46(3):482-7. PubMed ID: 25586016
[TBL] [Abstract] [Full Text] [Related]
12. Label-free impedimetric immunosensor for ultrasensitive detection of cancer marker Murine double minute 2 in brain tissue.
Elshafey R; Tlili C; Abulrob A; Tavares AC; Zourob M
Biosens Bioelectron; 2013 Jan; 39(1):220-5. PubMed ID: 22898660
[TBL] [Abstract] [Full Text] [Related]
13. Characterization of novel and complex genomic aberrations in glioblastoma using a 32K BAC array.
Nord H; Hartmann C; Andersson R; Menzel U; Pfeifer S; Piotrowski A; Bogdan A; Kloc W; Sandgren J; Olofsson T; Hesselager G; Blomquist E; Komorowski J; von Deimling A; Bruder CE; Dumanski JP; Díaz de Ståhl T
Neuro Oncol; 2009 Dec; 11(6):803-18. PubMed ID: 19304958
[TBL] [Abstract] [Full Text] [Related]
14. p53-independent mechanisms regulate the P2-mdm2 promoter in adult astrocytic tumours.
Dimitriadi M; Poulogiannis G; Liu L; Bäcklund LM; Pearson DM; Ichimura K; Collins VP
Br J Cancer; 2008 Oct; 99(7):1144-52. PubMed ID: 18781178
[TBL] [Abstract] [Full Text] [Related]
15. Molecular genetic study of a metastatic oligodendroglioma.
Giordana MT; Ghimenti C; Leonardo E; Balteri I; Iudicello M; Duò D
J Neurooncol; 2004 Feb; 66(3):265-71. PubMed ID: 15015656
[TBL] [Abstract] [Full Text] [Related]
16. p53, mdm2, EGFR, and msh2 expression in paired initial and recurrent glioblastoma multiforme.
Stark AM; Witzel P; Strege RJ; Hugo HH; Mehdorn HM
J Neurol Neurosurg Psychiatry; 2003 Jun; 74(6):779-83. PubMed ID: 12754350
[TBL] [Abstract] [Full Text] [Related]
17. Genetic alterations commonly found in diffusely infiltrating cerebral gliomas are rare or absent in pleomorphic xanthoastrocytomas.
Kaulich K; Blaschke B; Nümann A; von Deimling A; Wiestler OD; Weber RG; Reifenberger G
J Neuropathol Exp Neurol; 2002 Dec; 61(12):1092-9. PubMed ID: 12484572
[TBL] [Abstract] [Full Text] [Related]
18. Gliomatosis cerebri: molecular pathology and clinical course.
Herrlinger U; Felsberg J; Küker W; Bornemann A; Plasswilm L; Knobbe CB; Strik H; Wick W; Meyermann R; Dichgans J; Bamberg M; Reifenberger G; Weller M
Ann Neurol; 2002 Oct; 52(4):390-9. PubMed ID: 12325066
[TBL] [Abstract] [Full Text] [Related]
19. Molecular genetic analysis of the TP53, PTEN, CDKN2A, EGFR, CDK4 and mdm2 tumour-associated genes in supratentorial primitive neuroectodermal tumours and glioblastomas of childhood.
Kraus JA; Felsberg J; Tonn JC; Reifenberger G; Pietsch T
Neuropathol Appl Neurobiol; 2002 Aug; 28(4):325-33. PubMed ID: 12175345
[TBL] [Abstract] [Full Text] [Related]
20. Homozygous deletion of INK4a/ARF genes and overexpression of bcl-2 in relation with poor prognosis in immunocompetent patients with primary central nervous system lymphoma of the diffuse large B-cell type.
Hayashi Y; Iwato M; Arakawa Y; Fujisawa H; Thoma Y; Hasegawa M; Tachibana O; Yamashita J
J Neurooncol; 2001 Oct; 55(1):51-8. PubMed ID: 11804283
[TBL] [Abstract] [Full Text] [Related]
[Next]
